LNC
43
8
LMT
49
-6
SEE
42
-2
UNP
36
3
STT
65
6
AIZ
40
-16
PNW
52
-3
JNJ
51
10
HUM
39
2
SWKS
38
-10
PNC
59
2
BK
68
2
JCI
50
-10
ZION
59
2
PFG
33
-3
PAYX
47
-3
NEM
61
-3
PX
45
-3
BWA
36
3
NTRS
64
2
LNC
43
8
LMT
49
-6
SEE
42
-2
UNP
36
3
STT
65
6
AIZ
40
-16
PNW
52
-3
JNJ
51
10
HUM
39
2
SWKS
38
-10
PNC
59
2
BK
68
2
JCI
50
-10
ZION
59
2
PFG
33
-3
PAYX
47
-3
NEM
61
-3
PX
45
-3
BWA
36
3
NTRS
64
2
Financhill
Back

Check Point Software Technologies Vs. Blueprint Medicines Industry Stock Comparison

Buy
53

CHKP
Check Point Software Technologies

Last Price:
$219.02
Seasonality Move:
4.31%
Buy
52

BPMC
Blueprint Medicines

Last Price:
$128.13
Seasonality Move:
11.22%
Buy
53
Check Point Software Technologies (CHKP) is a Buy

Is Check Point Software Technologies a Buy, Sell or Hold?

  • The current Check Point Software Technologies [CHKP] share price is $218.42. The Score for CHKP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CHKP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.12. The Score for BPMC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CHKP Stock Price Chart

What is Check Point Software Technologies's stock price today?

  • The Check Point Software Technologies share price today is $218.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHKP is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight selling pressure.

CHKP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 42.39 Sell
Chaikin Money Flow: -301869 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (218.98 - 229.4) Sell
Bollinger Bands (100): (211.87 - 227.61) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.03 Buy
Relative Strength Index (14 RSI): 75.53 Buy
Chaikin Money Flow: -1180116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.99 - 128.61) Buy
Bollinger Bands (100): (85.1 - 113.52) Buy

CHKP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 222.61 Sell
20-day SMA: 225.78 Sell
50-day SMA: 219.86 Sell
200-day SMA: 204.11 Buy
8-day EMA: 222.04 Sell
20-day EMA: 223.5 Sell
50-day EMA: 221.52 Sell
200-day EMA: 204.68 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.08 Buy
20-day SMA: 118.35 Buy
50-day SMA: 102.34 Buy
200-day SMA: 95.74 Buy
8-day EMA: 127.05 Buy
20-day EMA: 120.04 Buy
50-day EMA: 108.59 Buy
200-day EMA: 97.88 Buy

Check Point Software Technologies Earnings Growth & CHKP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.14 per share, an increase this year of $0.81 per share, and an increase next year of $0.90 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Check Point Software Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):